Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A randomized, double-blind, parallel group, proof of concept study of YM178 in comparison with placebo and tolterodine in patients with symptomatic overactive bladder
mirabegron
178-CL-008
NCT01604928
Urinary Bladder, Overactive
Phase 2
 
September 2016

Powered by ideaPoint, Inc.